If this file opens in Compatibility Mode using Microsoft Word, convert to the latest document format to avoid potential formatting issues.	

IP/OP RSH H-56740 BMT CTN 2203	

Types:      Research Oncology Treatment
Synonyms:  

Screening	Repeat 1 time	Cycle length: 1 day	Screening Labs	Perform every 1 day x1			Research tolerance: -0/+0 days	Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --		  	LIPID PANEL	Interval: --	Occurrences: --		  	LDH	Interval: --	Occurrences: --			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Pre-Conditioning	Repeat 1 time	Cycle length: 8 days	Day -14 to -7	Perform every 1 day x1			Research tolerance: -0/+0 days	Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	LDH	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --					
Cycle 1	Repeat 1 time	Cycle length: 28 days	Day 1 (Pre-transplant Day -1)	Perform every 1 day x1			Research tolerance: -0/+0 days	Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Medications
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Providers should give the patient a paper order to take to IDS for medication dispensing since this is a study supplied drug. IDS will use the paper order to fill the medication.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	LDH	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
				Day 3	Perform every 1 day x1			Research tolerance: -0/+0 days	Line Care
  	sodium chloride 0.9% flush 20 mL	Dose: 20 mL	Route: intravenous	PRN	Start: S					Hydration
  	sodium chloride 0.9 % infusion	Dose: 125 mL/hr	Route: intravenous	continuous	Start: S+5					Medications
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Providers should give the patient a paper order to take to IDS for medication dispensing since this is a study supplied drug. IDS will use the paper order to fill the medication.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	PK1- Pre-dose (within 90 minutes of receiving Ruxolitinib)
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	PK2- One hour post-dose (+/- 15 min)
			Labs
  	LDH	Interval: --	Occurrences: --				Day 7	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Procedures
  	ECG 12-LEAD	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 14	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 21	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Procedures
  	ECG 12-LEAD	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	PK1- Pre-dose (within 90 minutes of receiving Ruxolitinib)
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	PK2- One hour post-dose (+/- 15 min)
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 28	Perform every 1 day x1			Research tolerance: -0/+0 days	Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
					
Cycle 2	Repeat 1 time	Cycle length: 49 days	Day 1 (Day 28)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
			Labs
  	HLA SPECIMEN	Interval: --	Occurrences: --	Comments:	Draw 2- ACD yellow top tubes for HLA Typing (low Of high resolution) OR STR's (chimensm). NOTE the desired test here AND submit the HLA requisition with the sample 
Test Type:  STR- Monitoring Engraftment: Chimerism Detection by STR:
				Day 7	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 14	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 21	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 42	Perform every 1 day x1			Research tolerance: -0/+0 days	Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
				Day 49	Perform every 1 day x1			Research tolerance: -0/+0 days	Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
					
Cycle 3	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 56)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --		  	LIPID PANEL	Interval: --	Occurrences: --			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
				Day 7	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 14	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --				Day 21	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --					
Cycle 4	Repeat 1 time	Cycle length: 28 days	Day 1	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Please order/schedule disease restaging studies for D99 visit (BMbx and/or imaging as indicated)
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
				Day 14 (Day 99)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document KPS
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --		  	LIPID PANEL	Interval: --	Occurrences: --			Labs
  	LDH	Interval: --	Occurrences: --			Labs
  	HLA SPECIMEN	Interval: --	Occurrences: --	Comments:	Draw 2- ACD yellow top tubes for HLA Typing (low Of high resolution) OR STR's (chimensm). NOTE the desired test here AND submit the HLA requisition with the sample 
Test Type:  STR- Monitoring Engraftment: Chimerism Detection by STR:
					
Cycle 5	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 112)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 6	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 140)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document KPS
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 7	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 168)	Perform every 1 day x1			Research tolerance: -0/+0 days	Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 8	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 196)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 9	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 224)	Perform every 1 day x1			Research tolerance: -0/+0 days	Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 10	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 252)	Perform every 1 day x1			Research tolerance: -0/+0 days	Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 11	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 280)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	LDH	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 12	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 308)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 13	Repeat 1 time	Cycle length: 28 days	Day 1 (Post-transplant)	Perform every 1 day x1			Research tolerance: -0/+0 days	Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 14	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 364)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document KPS
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --		  	LIPID PANEL	Interval: --	Occurrences: --			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Blood sample for immune reconstitution
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 15	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 392)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
Cycle 16	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 420)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Please order/schedule disease restaging studies for D532/18 month visit (BMbx and/or imaging as indicated)
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)
					
18 Months Post-transplant	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 532)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Confirm disease re-evaluation done/scheduled
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --		  	LIPID PANEL	Interval: --	Occurrences: --					
24 Months Post-transplant	Repeat 1 time	Cycle length: 28 days	Day 1 (Day 730)	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document KPS
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Please order/schedule disease restaging studies for D730/24 month visit (BMbx and/or imaging as indicated)
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Vital Signs: Respiratory rate. Pulse rate, BP (systolic/ diastolic) and Temperature.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Ensure weight and height recorded.
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --					
EOT	Repeat 1 time	Cycle length: 28 days	Day 1	Perform every 1 day x1			Research tolerance: -0/+0 days	Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Acute GVHD assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document KPS
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Toxicity assessment
			Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: Once	Occurrences: --	Comments:	Document Infection assessment
			Labs
  	HCG QUANTITATIVE, SERUM	Interval: --	Occurrences: --	Comments:	For women of child-bearing potential; must be done prior to the first dose of study drug (only for females randomized for ruxolitinib)